Literature DB >> 19666813

Gemella asaccharolytica sp. nov., isolated from human clinical specimens.

Nurver Ulger-Toprak1,2, Paula H Summanen2, Chengxu Liu2, Marie-Claire Rowlinson2, Sydney M Finegold3,4.   

Abstract

Three strains of an unidentified Gram-stain-variable, fastidious, catalase-negative, capnophilic, non-spore-forming, coccus-shaped bacterium from human wound specimens were characterized by phenotypic and molecular taxonomic methods. Initially, these strains were anaerobic; with repeated culture, they became aerotolerant. Comparative 16S rRNA gene sequencing studies demonstrated that the unknown strains were genealogically homogeneous and constituted a novel subline within the genus Gemella. The unknown bacterium was readily distinguished from other Gemella species by biochemical tests. On the basis of both phylogenetic and phenotypic evidence, it is proposed that the unknown bacterium from clinical specimens be classified as Gemella asaccharolytica sp. nov. The type strain is WAL 1945J(T) (=ATCC BAA-1630(T) =CCUG 57045(T)).

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19666813     DOI: 10.1099/ijs.0.001966-0

Source DB:  PubMed          Journal:  Int J Syst Evol Microbiol        ISSN: 1466-5026            Impact factor:   2.747


  3 in total

1.  Gemella haemolysans inhibits the growth of the periodontal pathogen Porphyromonas gingivalis.

Authors:  Tomohiro Miyoshi; Shogo Oge; Satoshi Nakata; Yuji Ueno; Hidehiko Ukita; Reiko Kousaka; Yuki Miura; Nobuo Yoshinari; Akihiro Yoshida
Journal:  Sci Rep       Date:  2021-06-03       Impact factor: 4.379

2.  Aerococcus christensenii as Part of Severe Polymicrobial Chorioamnionitis in a Pregnant Woman.

Authors:  Catrine Carlstein; Lillian Marie Søes; Jens Jørgen Christensen
Journal:  Open Microbiol J       Date:  2016-03-10

3.  Gemella massiliensis sp. nov., a new bacterium isolated from the human sputum.

Authors:  Maxime Descartes Mbogning Fonkou; Cheikh Ibrahima Lo; Zouina Mekhalif; Melhem Bilen; Enora Tomei; Edmond Kuete Yimagou; Grégory Dubourg; Didier Raoult; Florence Fenollar; Pierre-Edouard Fournier
Journal:  Arch Microbiol       Date:  2021-08-21       Impact factor: 2.552

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.